2013 Q2 Form 10-Q Financial Statement

#000119312513212440 Filed on May 10, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2013 Q1 2012 Q1
Revenue $324.3M $313.1M $192.5M
YoY Change 41.53% 62.64% 14.75%
Cost Of Revenue $103.7M $100.7M $52.19M
YoY Change 56.67% 92.93% 2.94%
Gross Profit $220.6M $212.4M $140.3M
YoY Change 35.37% 51.38% 19.87%
Gross Profit Margin 68.02% 67.84% 72.89%
Selling, General & Admin $21.51M $20.43M $17.22M
YoY Change 21.21% 18.68% 8.27%
% of Gross Profit 9.75% 9.62% 12.27%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $69.50M $63.50M $45.60M
YoY Change 31.88% 39.25% -39.12%
% of Gross Profit 31.51% 29.9% 32.5%
Operating Expenses $21.51M $20.43M $17.22M
YoY Change 21.21% 18.68% -81.02%
Operating Profit $49.53M $56.77M $40.29M
YoY Change 42.59% 40.89% 68.58%
Interest Expense -$78.50M $59.47M $42.25M
YoY Change -278.81% 40.75% -205.62%
% of Operating Profit -158.48% 104.76% 104.86%
Other Income/Expense, Net -$83.56M -$79.78M -$61.61M
YoY Change -4.09% 29.49% 287.5%
Pretax Income -$34.02M -$23.02M -$21.32M
YoY Change -35.05% 7.94% -36.72%
Income Tax $1.875M -$641.0K $1.327M
% Of Pretax Income
Net Earnings -$35.90M -$22.38M -$22.63M
YoY Change -32.86% -1.13% -33.93%
Net Earnings / Revenue -11.07% -7.15% -11.76%
Basic Earnings Per Share
Diluted Earnings Per Share -$281.1K -$176.2K -$190.2K
COMMON SHARES
Basic Shares Outstanding 127.6M shares 127.0M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q2 2013 Q1 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $194.8M $126.4M $531.3M
YoY Change 112.2% -76.21% 445.48%
Cash & Equivalents $189.4M $122.2M $525.6M
Short-Term Investments $5.400M $4.200M $5.700M
Other Short-Term Assets $73.80M $67.20M $32.40M
YoY Change -55.83% 107.41% -20.39%
Inventory
Prepaid Expenses $37.44M $40.33M
Receivables $47.78M $49.46M $40.90M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $352.1M $269.9M $604.6M
YoY Change 16.14% -55.35% 248.67%
LONG-TERM ASSETS
Property, Plant & Equipment $2.570B $2.655B $1.575B
YoY Change 24.37% 68.57% 2.41%
Goodwill
YoY Change
Intangibles $3.088B $3.085B
YoY Change 45.58%
Long-Term Investments
YoY Change
Other Assets $393.9M $375.5M $262.3M
YoY Change 50.48% 43.16% 17.1%
Total Long-Term Assets $6.132B $6.180B $3.482B
YoY Change -2.54% 77.48% 5.74%
TOTAL ASSETS
Total Short-Term Assets $352.1M $269.9M $604.6M
Total Long-Term Assets $6.132B $6.180B $3.482B
Total Assets $6.485B $6.450B $4.087B
YoY Change -1.68% 57.83% 17.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $24.10M $22.71M $13.10M
YoY Change 43.18% 73.39% 0.77%
Accrued Expenses $39.98M $39.41M $44.40M
YoY Change 27.03% -11.23% 1.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $10.00M $478.5M $5.000M
YoY Change -98.91% 9469.08%
Total Short-Term Liabilities $212.9M $675.1M $113.9M
YoY Change -79.74% 492.75% -5.24%
LONG-TERM LIABILITIES
Long-Term Debt $5.631B $4.885B $3.565B
YoY Change 82.16% 37.03% 18.64%
Other Long-Term Liabilities $204.7M $192.8M $135.9M
YoY Change 28.57% 41.84% 17.56%
Total Long-Term Liabilities $5.836B $5.078B $3.701B
YoY Change 79.53% 37.21% 18.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $212.9M $675.1M $113.9M
Total Long-Term Liabilities $5.836B $5.078B $3.701B
Total Liabilities $6.049B $5.753B $3.827B
YoY Change 40.62% 50.33% 17.64%
SHAREHOLDERS EQUITY
Retained Earnings -$2.520B -$2.485B
YoY Change 6.92%
Common Stock $1.278M $1.273M
YoY Change 5.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $435.7M $696.6M $259.6M
YoY Change
Total Liabilities & Shareholders Equity $6.485B $6.450B $4.087B
YoY Change 35.27% 57.83% 17.9%

Cashflow Statement

Concept 2013 Q2 2013 Q1 2012 Q1
OPERATING ACTIVITIES
Net Income -$35.90M -$22.38M -$22.63M
YoY Change -32.86% -1.13% -33.93%
Depreciation, Depletion And Amortization $69.50M $63.50M $45.60M
YoY Change 31.88% 39.25% -39.12%
Cash From Operating Activities $134.0M $94.23M $66.04M
YoY Change 59.33% 42.68% 24.14%
INVESTING ACTIVITIES
Capital Expenditures -$33.80M $36.42M $24.85M
YoY Change 44.44% 46.56% -223.03%
Acquisitions $47.18M $209.5M $51.15M
YoY Change -94.76% 309.68%
Other Investing Activities -$47.00M -$1.308M -$110.0K
YoY Change -94.79% 1089.09% -99.88%
Cash From Investing Activities -$80.70M -$244.7M -$75.89M
YoY Change -91.28% 222.38% -30.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $283.9M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 15.20M 37.80M 488.1M
YoY Change -96.22% -92.26% 464.92%
NET CHANGE
Cash From Operating Activities 134.0M 94.23M 66.04M
Cash From Investing Activities -80.70M -244.7M -75.89M
Cash From Financing Activities 15.20M 37.80M 488.1M
Net Change In Cash 68.50M -112.6M 478.2M
YoY Change -115.61% -123.55% 1447.71%
FREE CASH FLOW
Cash From Operating Activities $134.0M $94.23M $66.04M
Capital Expenditures -$33.80M $36.42M $24.85M
Free Cash Flow $167.8M $57.81M $41.19M
YoY Change 56.09% 40.34% -43.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
29.56
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2013Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
696645000
CY2013Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3859759000
CY2013Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
63564000
CY2013Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
1300000
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4345000
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
675138000
CY2013Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
5430247000
CY2013Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
1300000
CY2013Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
38870000
CY2013Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
72148000
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
127597366 shares
CY2009Q2 sbac Financing Fee Recorded As Reduction To Shareholders Equity
FinancingFeeRecordedAsReductionToShareholdersEquity
4000000
CY2009Q2 sbac Deferred Financing Fees
DeferredFinancingFees
7700000
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
525554000
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2484552000
CY2013Q1 us-gaap Assets
Assets
6449885000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
122230000
CY2013Q1 us-gaap Short Term Investments
ShortTermInvestments
4166000
CY2013Q1 us-gaap Billings In Excess Of Cost
BillingsInExcessOfCost
1221000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.44
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
49463000
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
355000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3547000 shares
CY2013Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4153966000
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
375509000
CY2013Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
26880000
CY2013Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
40327000
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6449885000
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
127300000 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
312000 shares
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
1273000
CY2013Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
774300000
CY2013Q1 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs
CostsInExcessOfBillingsOnUncompletedContractsOrPrograms
25657000
CY2013Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
18269000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1746000 shares
CY2013Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5078102000
CY2013Q1 us-gaap Long Term Debt
LongTermDebt
5363793000
CY2013Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3085459000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
54.12
CY2013Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
39413000
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2655409000
CY2013Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
478454000
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126933000 shares
CY2013Q1 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected Within One Year
CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear
26878000
CY2013Q1 us-gaap Interest Payable Current
InterestPayableCurrent
44140000
CY2013Q1 us-gaap Assets Current
AssetsCurrent
269944000
CY2013Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3175579000
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1498557000
CY2013Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4885339000
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
696645000
CY2013Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
192763000
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
22714000
CY2013Q1 sbac Performance Targets Maximum Potential Obligation
PerformanceTargetsMaximumPotentialObligation
15900000
CY2013Q1 sbac Accounts Receivable Number Of Customers
AccountsReceivableNumberOfCustomers
5 Customer
CY2013Q1 sbac Treasury Stock Repurchase Value Authorized
TreasuryStockRepurchaseValueAuthorized
150000000
CY2013Q1 sbac Weighted Average Exercise Price Per Option Expected To Unvested At Closing
WeightedAverageExercisePricePerOptionExpectedToUnvestedAtClosing
58.86
CY2013Q1 sbac Surety Payment And Performance Bonds
SuretyPaymentAndPerformanceBonds
34800000
CY2013Q1 sbac Number Of Options Unvested At Closing
NumberOfOptionsUnvestedAtClosing
1801000 shares
CY2013Q1 sbac Certificate Of Deposits
CertificateOfDeposits
4000000
CY2013Q1 sbac Collateral For Surety Payment And Performance Bonds
CollateralForSuretyPaymentAndPerformanceBonds
10500000
CY2013Q1 sbac Accrued Earnouts
AccruedEarnouts
8900000
CY2013Q1 sbac Concentration Risk Percentage Of Accounts Receivable
ConcentrationRiskPercentageOfAccountsReceivable
0.555 pure
CY2013Q1 sbac Concentration Risk Percentage Of Revenue Minimum
ConcentrationRiskPercentageOfRevenueMinimum
0.10 pure
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47316000
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
652991000
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3846534000
CY2012Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
66324000
CY2012Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
1500000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2791000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
863688000
CY2012Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
5440073000
CY2012Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
1500000
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
39697000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
76668000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2462176000
CY2012Q4 us-gaap Assets
Assets
6595617000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
233099000
CY2012Q4 us-gaap Short Term Investments
ShortTermInvestments
5471000
CY2012Q4 us-gaap Billings In Excess Of Cost
BillingsInExcessOfCost
1120000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
34.06
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
39099000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
246000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2831000 shares
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4109522000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
355280000
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
27708000
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
39542000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6595617000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
127300000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
294000 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
1269000
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
712401000
CY2012Q4 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs
CostsInExcessOfBillingsOnUncompletedContractsOrPrograms
22524000
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
195690000
CY2012Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5067227000
CY2012Q4 us-gaap Long Term Debt
LongTermDebt
5356103000
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3134133000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
43.27
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
42052000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2671317000
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
475351000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126933000 shares
CY2012Q4 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected Within One Year
CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear
23644000
CY2012Q4 us-gaap Interest Payable Current
InterestPayableCurrent
46233000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
368563000
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3111107000
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1438205000
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4880752000
CY2012Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
11711000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
652991000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
186475000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
27694000
CY2012Q4 sbac Accounts Receivable Number Of Customers
AccountsReceivableNumberOfCustomers
5 Customer
CY2012Q4 sbac Surety Payment And Performance Bonds
SuretyPaymentAndPerformanceBonds
35100000
CY2012Q4 sbac Certificate Of Deposits
CertificateOfDeposits
5300000
CY2012Q4 sbac Collateral For Surety Payment And Performance Bonds
CollateralForSuretyPaymentAndPerformanceBonds
10500000
CY2012Q4 sbac Accrued Earnouts
AccruedEarnouts
9800000
CY2012Q4 sbac Concentration Risk Percentage Of Accounts Receivable
ConcentrationRiskPercentageOfAccountsReceivable
0.555 pure
CY2012Q3 sbac Write Off Of Debt Discount
WriteOffOfDebtDiscount
1000000
CY2012Q3 sbac Write Off Of Unamortized Deferred Financing Costs
WriteOffOfUnamortizedDeferredFinancingCosts
3400000
CY2012Q3 sbac Premium Paid On Redemption Of Debt
PremiumPaidOnRedemptionOfDebt
14600000
CY2009Q2 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
11700000
CY2013Q2 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2013-05-01
CY2012 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
17300000
CY2012 sbac Number Of Customers
NumberOfCustomers
5 Customer
CY2012 sbac Costs And Estimated Earnings In Excess Of Billings On Uncompleted Contracts Net
CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet
0.865 pure
CY2013Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q1 dei Document Type
DocumentType
10-Q
CY2013Q1 dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
CY2013Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001034054
CY2013Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q1 dei Trading Symbol
TradingSymbol
SBAC
CY2013Q1 dei Entity Registrant Name
EntityRegistrantName
SBA COMMUNICATIONS CORP
CY2013Q1 dei Amendment Flag
AmendmentFlag
false
CY2013Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
152000
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y1M13D
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0060 pure
CY2013Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
17364000
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M1D
CY2013Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
395000
CY2013Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
193000 shares
CY2013Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-656000
CY2013Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
209542000
CY2013Q1 us-gaap Profit Loss
ProfitLoss
-22376000
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-244657000
CY2013Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
641000
CY2013Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1653000
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
30.61
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
72.99
CY2013Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
4500000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
26000 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
42.19
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1554000
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-23017000
CY2013Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
6008000
CY2013Q1 us-gaap Interest Paid
InterestPaid
61627000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
8100000
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
72.99
CY2013Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
168000
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-110869000
CY2013Q1 us-gaap Operating Leases Income Statement Initial Direct Costs
OperatingLeasesIncomeStatementInitialDirectCosts
68101000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
56765000
CY2013Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
615000
CY2013Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P6Y2M5D
CY2013Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3910000
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
43.29
CY2013Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
100695000
CY2013Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
5308000
CY2013Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1554000
CY2013Q1 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
300000000
CY2013Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
17364000
CY2013Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
125636000
CY2013Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1802000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-22376000
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-79782000
CY2013Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
13688000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
935000 shares
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
256306000
CY2013Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
273504000
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
37801000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
43.17
CY2013Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
851000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20822000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
87000 shares
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
18434000
CY2013Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-2094000
CY2013Q1 us-gaap Revenues
Revenues
313071000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0081 pure
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20431000
CY2013Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P15Y
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-641000
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1759000
CY2013Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4325000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
6000 shares
CY2013Q1 us-gaap Depreciation
Depreciation
63500000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
111000 shares
CY2013Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
4325000
CY2013Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
213000
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36423000
CY2013Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
2900000
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
62000000
CY2013Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9200000
CY2013Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1308000
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3874000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-20822000
CY2013Q1 us-gaap Interest Expense
InterestExpense
59465000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
17.29
CY2013Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
5308000
CY2013Q1 us-gaap Derivative Cash Received On Hedge
DerivativeCashReceivedOnHedge
45300000
CY2013Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-142000
CY2013Q1 us-gaap Proceeds From Hedge Financing Activities
ProceedsFromHedgeFinancingActivities
45230000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2013Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
5822000
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
94228000
CY2013Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3604000
CY2013Q1 sbac Credit Facility Interest Rate
CreditFacilityInterestRate
0.01875 pure
CY2013Q1 sbac Number Of Customers
NumberOfCustomers
5 Customer
CY2013Q1 sbac Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
127057000 shares
CY2013Q1 sbac Potential Obligations To Pay Additional Consideration Recorded In Accrued Expenses
PotentialObligationsToPayAdditionalConsiderationRecordedInAccruedExpenses
8900000
CY2013Q1 sbac Noncash Interest Expense
NoncashInterestExpense
17364000
CY2013Q1 sbac Number Of Towers Acquired
NumberOfTowersAcquired
41 Tower
CY2013Q1 sbac Towers And Related Intangible Assets Acquisitions
TowersAndRelatedIntangibleAssetsAcquisitions
195753000
CY2013Q1 sbac Supplemental Assets Acquired Under Capital Leases
SupplementalAssetsAcquiredUnderCapitalLeases
436000
CY2013Q1 sbac Site Development
SiteDevelopment
39567000
CY2013Q1 sbac Earnouts
Earnouts
401000
CY2013Q1 sbac Convertible Notes Conversion Criteria Associated With Common Stock And Convertible Notes Trading Price
ConvertibleNotesConversionCriteriaAssociatedWithCommonStockAndConvertibleNotesTradingPrice
Trading price per $1,000 principal amount of the Notes for each day in the measurement period was less than 95% of the product of the last reported sale price of Class A common stock
CY2013Q1 sbac Convertible Notes Conversion Criteria Associated With Common Stock Trading Price
ConvertibleNotesConversionCriteriaAssociatedWithCommonStockTradingPrice
The last reported sale price of the Company's Class A common stock for at least 20 trading days in the 30 consecutive trading day period ending on the last trading day of the preceding calendar quarter is more than 130% of the applicable conversion price per share of Class A common stock on the last day of such preceding calendar quarter
CY2013Q1 sbac Ground Lease Extensions
GroundLeaseExtensions
1700000
CY2013Q1 sbac Ground Lease Land Purchases
GroundLeaseLandPurchases
13388000
CY2013Q1 sbac Cost Of Site Development
CostOfSiteDevelopment
32594000
CY2013Q1 sbac Capital Expenditures
CapitalExpenditures
246401000
CY2013Q1 sbac Costs And Estimated Earnings In Excess Of Billings On Uncompleted Contracts Net
CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet
0.907 pure
CY2012Q1 sbac Towers And Related Intangible Assets Acquisitions
TowersAndRelatedIntangibleAssetsAcquisitions
43715000
CY2012Q1 sbac Supplemental Assets Acquired Under Capital Leases
SupplementalAssetsAcquiredUnderCapitalLeases
299000
CY2013Q1 sbac Adjustment To Redemption Value For Noncontrolling Interest
AdjustmentToRedemptionValueForNoncontrollingInterest
-5701000
CY2013Q1 sbac Cash Interest Expense
CashInterestExpense
59465000
CY2013Q1 sbac Business Acquisition Contingent Consideration Income Expense Net
BusinessAcquisitionContingentConsiderationIncomeExpenseNet
600000
CY2013Q1 sbac Asset Impairment And Decommission Costs
AssetImpairmentAndDecommissionCosts
3722000
CY2013Q1 sbac Noncash Asset Impairment And Decommission Costs
NoncashAssetImpairmentAndDecommissionCosts
2892000
CY2012Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12000
CY2012Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
200000000
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0062 pure
CY2012Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
16991000
CY2012Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
6054000
CY2012Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
51148000
CY2012Q1 us-gaap Profit Loss
ProfitLoss
-22651000
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-75890000
CY2012Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
47000
CY2012Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
419000
CY2012Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
1250000
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-21324000
CY2012Q1 us-gaap Interest Paid
InterestPaid
49997000
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5500000
CY2012Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
149000
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
478238000
CY2012Q1 us-gaap Operating Leases Income Statement Initial Direct Costs
OperatingLeasesIncomeStatementInitialDirectCosts
35407000
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
40289000
CY2012Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
83000
CY2012Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
52193000
CY2012Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
742000
CY2012Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
291000
CY2012Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
82100000
CY2012Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
17000
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-22631000
CY2012Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-61613000
CY2012Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1259000
CY2012Q1 us-gaap Costs And Expenses
CostsAndExpenses
152201000
CY2012Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-20000
CY2012Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
172923000
CY2012Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
16991000
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
488091000
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.53 pure
CY2012Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
33000
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21909000
CY2012Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10143000
CY2012Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-7681000
CY2012Q1 us-gaap Revenues
Revenues
192490000
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0083 pure
CY2012Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17215000
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1327000
CY2012Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-3000
CY2012Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-20000
CY2012Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
5763000
CY2012Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3293000
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24852000
CY2012Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
300000
CY2012Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
36400000
CY2012Q1 us-gaap Depreciation
Depreciation
45600000
CY2012Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-110000
CY2012Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3057000
CY2012Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-21889000
CY2012Q1 us-gaap Interest Expense
InterestExpense
42248000
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
20.28
CY2012Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
283902000
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2012Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
344000
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
66040000
CY2012Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2433000
CY2012Q1 sbac Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
111431000 shares
CY2012Q1 sbac Noncash Interest Expense
NoncashInterestExpense
16991000
CY2012Q1 sbac Site Development
SiteDevelopment
19567000
CY2012Q1 sbac Earnouts
Earnouts
1762000
CY2012Q1 sbac Ground Lease Extensions
GroundLeaseExtensions
1500000
CY2012Q1 sbac Ground Lease Land Purchases
GroundLeaseLandPurchases
5671000
CY2012Q1 sbac Cost Of Site Development
CostOfSiteDevelopment
16786000
CY2012Q1 sbac Capital Expenditures
CapitalExpenditures
76299000
CY2012Q1 sbac Cash Interest Expense
CashInterestExpense
42248000
CY2012Q1 sbac Business Acquisition Contingent Consideration Income Expense Net
BusinessAcquisitionContingentConsiderationIncomeExpenseNet
1400000
CY2012Q1 sbac Asset Impairment And Decommission Costs
AssetImpairmentAndDecommissionCosts
349000
CY2012Q1 sbac Noncash Asset Impairment And Decommission Costs
NoncashAssetImpairmentAndDecommissionCosts
349000

Files In Submission

Name View Source Status
0001193125-13-212440-index-headers.html Edgar Link pending
0001193125-13-212440-index.html Edgar Link pending
0001193125-13-212440.txt Edgar Link pending
0001193125-13-212440-xbrl.zip Edgar Link pending
d515614d10q.htm Edgar Link pending
d515614dex1086o.htm Edgar Link pending
d515614dex311.htm Edgar Link pending
d515614dex312.htm Edgar Link pending
d515614dex321.htm Edgar Link pending
d515614dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sbac-20130331.xml Edgar Link completed
sbac-20130331.xsd Edgar Link pending
sbac-20130331_cal.xml Edgar Link unprocessable
sbac-20130331_def.xml Edgar Link unprocessable
sbac-20130331_lab.xml Edgar Link unprocessable
sbac-20130331_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending